Cargando…
Intraocular pressure improvement in patients receiving teprotumumab for the treatment of thyroid eye disease: a case series
BACKGROUND: Teprotumumab is a novel treatment that reduces inflammation and symptoms caused by thyroid eye disease. There are limited data on teprotumumab’s effect on intraocular pressure. CASE PRESENTATION: We report nine patients diagnosed with thyroid eye disease whose intraocular pressure decrea...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087984/ https://www.ncbi.nlm.nih.gov/pubmed/35538553 http://dx.doi.org/10.1186/s13256-022-03375-x |